<DOC>
	<DOCNO>NCT00647491</DOCNO>
	<brief_summary>The primary objective study evaluate safety , efficacy pharmacokinetics three dos adalimumab adult Japanese subject RA</brief_summary>
	<brief_title>A Study Adalimumab Adult Japanese Subjects With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Meet ACR criterion diagnosis active RA screening baseline visit &gt; 10 swollen joint , &gt; 12 tender joint . Subjects must fail prior treatment one DMARDs . A negative ( serum ) pregnancy test female subject childbearing potential screening negative ( urine ) pregnancy test prior study drug administration . Body weight less equal 100 kg A history , current , acute inflammatory joint disease different origin RA . Prior treatment TNF antagonist , include adalimumab . Any ongoing chronic active infection major episode infection require hospitalization treatment IV antibiotic . Unstable ischemic heart disease , active inflammatory bowel disease , active peptic ulcer disease , recent stroke poorly control medical condition .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>